Labroots
Upgrading the CRISPR Toolbox - New Strategies Sharpen the CRISPR-Cas9 Scissors Utilizing Visualization and Chromatic Accessibility
Watch Now
quanticate
There are approximately 7,000 distinct rare diseases affecting 350 million people worldwide, approximately 80 percent of which are caused by faulty genes. The US Food and Drug Administration (FDA) has more than 700 active Investigational New Drug Applications (INDs) for gene and cell therapies and in 2017, the FDA approved two cell-based gene therapies and it is anticipated that gene therapy will become a mainstay treatment for many rare diseases.
Watch Now
More than US$55 billion has been invested in developing gene modification and cell therapy platforms over the past three years. While the science has advanced, the practical components of launch and optimizing
Watch Now
Protein concentration is an obligatory critical quality attribute that is necessary to determine total protein content in biopharmaceutical formulations.
Watch Now